Codes ATC:
L01BC05
Indication
Other specified malignant neoplasms of bronchus or lung
Code ICD11:
2C75.Y
INN
Gemcitabine
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
Formulations
Parenteral > General injections > IV:
200 mg in vial powder for injection ;
1 g in vial powder for injection
Historique des statuts LME
Ajouté pour la première fois en 2015
(TRS
994)
Sexe
Tous
Âge
Adolescents et adultes
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, gemcitabine was added to the complementary list of the EML for use in treatment protocols for non-small cell lung cancer. The relevant extract from TRS994 regarding the Expert Committee's consideration of treatment protocols for non-small cell lung cancer is attached.